![](/img/cover-not-exists.png)
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel and Nintedanib for Resectable Non-Small Cell Lung Cancer.
Cascone, Tina, Sepesi, Boris, Lin, Heather, Kalhor, Neda, Parra, Edwin R., Jiang, Mei, Godoy, Myrna C.B., Zhang, Jianjun, Fossella, Frank, Tsao, Anne S., Lam, Vincent K, Lu, Charles, Mott, Frank E, SiJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-4180
Date:
March, 2020
File:
PDF, 2.76 MB
2020